HB2645 limits price increases for essential off-patent or generic drugs in Arizona.
HB2645 amends Arizona law to regulate price increases for essential off-patent or generic drugs. Manufacturers and wholesale distributors are prohibited from engaging in price gouging, defined as an unconscionable increase in the price of such drugs. The bill allows the attorney general to take enforcement actions, including civil penalties of up to $10,000 per violation, to address violations.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.